Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

BACKGROUND: Standard treatment of colorectal cancer includes both cytostatic chemotherapy and targeted therapies. Bevacizumab, targeting the VEGF receptor, is one of the primary targeted therapies that achieve better response rate and survival rate as compared to combination chemotherapy. To the bes...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Sümbül, Ahmet Taner, Dişel, Umut, Sezgin, Nurzen, Sezer, Ahmet, Köse, Fatih, Beşen, Ali Ayberk, Sümbül, Zehra, Abalı, Hüseyin, Özyılkan, Özgür
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: International Scientific Literature, Inc. 2014
Onderwerpen:
Clinical Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3962326/
https://ncbi.nlm.nih.gov/pubmed/24632679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.889945
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items